NEWS

News

3 May 2022
ICE GROUP acquires Iwaki manufacturing site from Mitbubishi API corporation
We are pleased to announce that on May 2nd ICE Group completed the purchase of the Iwaki Ursodeoxycholic Acid (“UDCA”) manufacturing site from Mitsubishi API Corporation. This transaction represents the end of an acquisition process that started in October 2021. Tokyo Tanabe…
16 December 2021
ICE GROUP acquires ABC Farmaceutici S.p.A.
We are pleased to announce that on December 15th ICE Group completed the acquisition of ABC Farmaceutici S.p.A (“ABC”). ABC is a pharmaceutical company based in Ivrea, Italy. Founded in 1925, the company is dedicated to the research, development, production and sale of…
9 December 2021
ICE Group Cogenerator Project in Basaluzzo manufacturing site
In May 2019 the cogenerator project was ended and realized. Project was supported by POS FESR PIEMONTE 2014-2020. The principal goals of the project were:    - reduction of energy costs derived from the large use of electricity and steam in production processes.    - the…
20 October 2021
ICE acquires Mitsubishi APIC’s Iwaki UDCA Plant
ICE Group, a global niche active pharmaceutical ingredient (“API”) and specialty ingredients company, is proud to announce its agreement on the definitive terms to acquire the Iwaki Ursodeoxycholic Acid (“UDCA”) manufacturing site from Mitsubishi API Corporation. The Iwaki…
3 June 2021
ICE Group - Vaccination Hub in Basaluzzo, Italy.
We’re glad to announce that starting from the 3rd of June 2021, in line with our commitment to sustain our territory, in particular during the fight against COVID-19, ICE has officially opened its own Vaccination HUB. Our Hub is located in Basaluzzo, near Alessandria, in a…